par Brunello, Nicoletta;Armitage, R;Feinberg, I;Holsboer-Trachsler, E;Léger, D;Linkowski, Paul
;Mendelson, W B;Racagni, G;Saletu, B;Sharpley, A L;Turek, Fred
;Van Cauter, Eve
;Mendlewicz, Julien 
Référence Neuropsychobiology, 42, 3, page (107-119)
Publication Publié, 2000




Référence Neuropsychobiology, 42, 3, page (107-119)
Publication Publié, 2000
Article révisé par les pairs
Titre: |
|
Auteur: | Brunello, Nicoletta; Armitage, R; Feinberg, I; Holsboer-Trachsler, E; Léger, D; Linkowski, Paul; Mendelson, W B; Racagni, G; Saletu, B; Sharpley, A L; Turek, Fred; Van Cauter, Eve; Mendlewicz, Julien |
Informations sur la publication: | Neuropsychobiology, 42, 3, page (107-119) |
Statut de publication: | Publié, 2000 |
Sujet CREF: | Sciences bio-médicales et agricoles |
MeSH keywords: | Antidepressive Agents -- adverse effects |
Antidepressive Agents -- economics | |
Antidepressive Agents -- therapeutic use | |
Cost of Illness | |
Cost-Benefit Analysis | |
Depressive Disorder -- drug therapy | |
Depressive Disorder -- economics | |
Humans | |
Hypnotics and Sedatives -- adverse effects | |
Hypnotics and Sedatives -- economics | |
Hypnotics and Sedatives -- therapeutic use | |
Italy | |
Sleep Initiation and Maintenance Disorders -- drug therapy | |
Sleep Initiation and Maintenance Disorders -- economics | |
Sleep Stages -- drug effects | |
Note générale: | Consensus Development Conference |
Journal Article | |
Review | |
Langue: | Anglais |
Identificateurs: | urn:issn:0302-282X |
info:pii/nps42107 | |
info:pmid/11015028 |